MedPath

sex hormones in coronavirus

Phase 2
Recruiting
Conditions
Severity of COVID-19.
Coronavirus infection, unspecified
B34.2
Registration Number
IRCT20150716023235N15
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

COVID-19 patients with respiratory, heart or kidney failure

Exclusion Criteria

History of breast cancer in females
History of prostate cancer in males
History of thromboembolism in both sexes
Suspected breast examination in women
High PSA in primary laboratory tests

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of disease. Timepoint: before intervention and every week until one month. Method of measurement: observation.;IL-6. Timepoint: before intervention and every week until one month. Method of measurement: Elisa.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath